Esophageal tolerance to high-dose stereotactic ablative radiotherapy
Diseases of the Esophagus, 04/25/2012Abelson JA et al.
The authors report a dosimetric analysis of incidental dose to the esophagus from stereotactic ablative radiotherapy (SABR). High–dose hypofractionated radiotherapy led to a number of high–grade esophageal adverse events, suggesting that conservative parameters to protect the esophagus are necessary when SABR is used, especially in the setting of chemotherapy or prior radiotherapy.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.